Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Is testing for growth hormone release necessary?

¹Department of Pediatrics, Stanford University, California, USA.

Kidney International. Supplement

|January 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patients', family members' and healthcare practitioners' experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis: a qualitative descriptive study using emotional touchpoints.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Same author

The psychological impact of Stevens-Johnson syndrome and toxic epidermal necrolysis on patients' lives: a Critically Appraised Topic.

The British journal of dermatology·2019

Same author

DNA Polymerase Beta Participates in Mitochondrial DNA Repair.

Molecular and cellular biology·2017

Same author

Dicarboxylic acids as pH sensors for hyperpolarized <sup>13</sup>C magnetic resonance spectroscopic imaging.

The Analyst·2017

Same author

Arachidonic acid: Occurrence in the reproductive tract of the male house cricket (Acheta domesticus) and field cricket (Gryllus spp.).

Lipids·2016

Same author

[(11)C]Ascorbic and [(11)C]dehydroascorbic acid, an endogenous redox pair for sensing reactive oxygen species using positron emission tomography.

Chemical communications (Cambridge, England)·2016

Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011

Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011

Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011

Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011

Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011

Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011

See all related articles

Testing growth hormone release is crucial for children with chronic renal failure (CRF) to determine the necessity of growth hormone (GH) therapy. Accurate diagnostic tests for the GH-IGF axis aid in managing these pediatric patients effectively.

Area of Science:

Pediatric Endocrinology
Nephrology
Diagnostic Testing

Background:

The necessity of testing for growth hormone release in pediatric patients with chronic renal failure (CRF) is debated.
Defining growth hormone deficiency (GHD) and identifying patients who benefit from growth hormone (GH) therapy are evolving clinical questions.
Children with CRF generally respond to GH therapy, shifting the focus to when testing is appropriate.

Purpose of the Study:

To evaluate the role and necessity of growth hormone release testing in children with CRF.
To discuss the importance of diagnosing GHD for treatment implications, including neonatal hypoglycemia and identifying underlying pathologies.
To assess the utility of diagnostic tests for the growth hormone-insulin-like growth factor (GH-IGF) axis in managing these children.

Related Experiment Videos

Main Methods:

Review of diagnostic approaches for evaluating the GH-IGF axis.
Discussion of criteria for a "good" diagnostic test: rational connection, concordance with outcome, accuracy, and reproducibility.
Consideration of various tests including GH stimulation tests, 24-hour GH profiles, IGF-I, and IGFBP-3 levels.

Main Results:

High-quality determinations of IGF-I and IGFBP-3 are valuable for assessing the GH-IGF axis.
The abstract implies that while children with CRF respond to GH therapy, the timing and necessity of diagnostic testing remain key considerations.
The criteria for effective diagnostic tests highlight the need for reliable and relevant assessments.

Conclusions:

The focus is shifting from diagnosing GHD to identifying patients who will respond to GH therapy, particularly in conditions like CRF.
Effective diagnostic tests for the GH-IGF axis are essential for guiding management decisions in children with potential growth issues.
Accurate and reproducible tests like IGF-I and IGFBP-3 measurements are crucial for evaluating the GH-IGF axis in pediatric patients.